These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15779352)

  • 1. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
    Yoshimoto K; Ozawa S; Ishida H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impaired glucose tolerance in children and adolescents].
    Nakanishi T; Sai S; Fujisawa Y; Nakagawa Y; Ohzeki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():345-8. PubMed ID: 15779401
    [No Abstract]   [Full Text] [Related]  

  • 4. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited.
    Ceriello A; Motz E
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):816-23. PubMed ID: 14976002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin deficiency vs insulin resistance in NIDDM: concluding remarks by a 'biased' observer.
    Cerasi E
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S161-4. PubMed ID: 8894502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in glucose tolerance in elderly].
    Lerman-Garber I; Rosales-Calderón M
    Rev Invest Clin; 2010; 62(4):312-7. PubMed ID: 21222309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pathogenesis of insulin resistance in IGT].
    Asakawa H; Tokunaga K
    Nihon Rinsho; 1997 Nov; 55 Suppl():822-6. PubMed ID: 9434571
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxidative stress, insulin secretion, and insulin resistance].
    Poitout V; Tanaka Y; Reach G; Robertson RP
    Journ Annu Diabetol Hotel Dieu; 2001; ():75-86. PubMed ID: 11565471
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular basis for the development of type 2 diabetes mellitus].
    Kasuga M
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():468-76. PubMed ID: 12238086
    [No Abstract]   [Full Text] [Related]  

  • 11. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.
    Marchetti P; Lupi R; Del Guerra S; Bugliani M; D'Aleo V; Occhipinti M; Boggi U; Marselli L; Masini M
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S178-83. PubMed ID: 19875548
    [No Abstract]   [Full Text] [Related]  

  • 12. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of nateglinide in impaired glucose tolerance subjects].
    Hirose T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():438-43. PubMed ID: 15779419
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin resistance as the core defect in type 2 diabetes mellitus.
    Goldstein BJ
    Am J Cardiol; 2002 Sep; 90(5A):3G-10G. PubMed ID: 12231073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular pathogenesis of type 2 diabetes mellitus].
    Kadowaki T
    Seikagaku; 1999 Nov; 71(11):1281-98. PubMed ID: 10614177
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
    Tatoń J; Koliński P
    Pol Tyg Lek; 1985 May; 40(18):505-11. PubMed ID: 3892513
    [No Abstract]   [Full Text] [Related]  

  • 17. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy.
    Matveyenko AV; Veldhuis JD; Butler PC
    Diabetes; 2006 Aug; 55(8):2347-56. PubMed ID: 16873700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of progression of atherosclerosis in patients with impaired glucose tolerance (IGT)].
    Watada H; Nomiyama T; Kawamori R
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():101-6. PubMed ID: 15779353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].
    Tanaka Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():361-5. PubMed ID: 15779404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.